CN1277864A - External application medicine for treating hypertension - Google Patents
External application medicine for treating hypertension Download PDFInfo
- Publication number
- CN1277864A CN1277864A CN 99109188 CN99109188A CN1277864A CN 1277864 A CN1277864 A CN 1277864A CN 99109188 CN99109188 CN 99109188 CN 99109188 A CN99109188 A CN 99109188A CN 1277864 A CN1277864 A CN 1277864A
- Authority
- CN
- China
- Prior art keywords
- medicine
- external application
- semen
- present
- treating hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to an external-applied medicine for treating hypertension. It is composed of semen momordicae, heichou, baichou and white pepper as raw materials, and is made into external-applied preparation and applied on specific position of human body, and its effect is very significant.
Description
The present invention relates to the hypertensive liniment of a kind of treatment, specifically is the external Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Hypertension is a kind of clinical syndrome that increases based on arteriotony, hypertension is in China adult, prevalence is 3～10%, it is the commonly encountered diseases of harm people ' s health, but hypertension cardiac trigger pathological changes, cause various acute cerebrovascular diseasees, cause a series of pathological changes such as nephrosclerosis, atrophic kidney.
At present, the antihypertensive drugs of doctor trained in Western medicine application is broadly divided into following ten classes: (1) central sympathetic nerve depressant: clonidine, methyldopa etc.; (2) ganglioplegic: mecamylamine, pempidine etc.; (3) SNE depressant: reserpine, verticil etc.; (4) α beta blocker: phentolamine, Phenoxybenzamine etc.; (5) Bextra: propranolol etc.; (6) α and Bextra: labetalol etc.; (7) vasodilator drug: diazoxide, Minoxidil etc.; (8) diuretic: two hydrogen chlorine piperazine etc. that rubs; (9) renin angiotensin aldosterone system depressant: BPP9 etc.; (10) calcium flux blockers: isoptin etc.Their ubiquities and need be taken medicine for a long time, can not effect a radical cure, toxic and side effects is big, as xerostomia, dizziness occur, feel sick, multiple untoward reaction such as vomiting, stomachache; Though have some to treat hypertensive Chinese patent medicine, effect is not fairly obvious yet.
The object of the present invention is to provide a kind of hypertension treatment agent with blood pressure lowering, removing water retention by purgation, therapeutic method to keep the adverse QI flowing downwards effect.
Therapeutic scheme of the present invention is based on motherland's medical science to hypertension and pathogenetic understanding of complication and Therapeutic Principle, treatment principle with reference to science of acupuncture and moxibustion apoplex involving the channels and collaterals, acupuncture point, filter out have blood pressure lowering, Chinese herbal medicine such as removing water retention by purgation, the therapeutic method to keep the adverse QI flowing downwards, external application acts on the human body specific part, reaches the effect of blood pressure lowering, treatment hypertension.
(consumption is a weight portion) that medicine of the present invention is made by following component:
Semen Momordicae 30-60, Semen Pharbitidis 15-45, Semen Pharbitidis 20-40, Radix orixae japonicae 1-4.
The proportioning of the optimum weight of medicine of the present invention (part):
Semen Momordicae 55, Semen Pharbitidis 30, Semen Pharbitidis 25, Radix orixae japonicae 1.5.
The method that above-mentioned each component is made medicine of the present invention is:
With Semen Momordicae, Semen Pharbitidis, Semen Pharbitidis, Radix orixae japonicae drying and crushing, powder particle diameter order number gets final product greater than 40 orders, afterwards, mixes when using, with medicine of the present invention and Ovum Gallus domesticus mixing, furnishing pasty state.Also medicine of the present invention can be made the leaching agent of water, wine, vinegar etc.
The coating part of medicine of the present invention is that the sp 6 of human body lower limbs is with lower limb, foot outer surface down to Yongquan acupoint, Xiangu point line.
An important feature of the present invention is to select medicine few, and antihypertensive effect is obvious, owing to only be used for external application, human body is had no adverse reaction.Another important feature is that selected the area of application is contained 6 of whole meridians meters totally 26 acupuncture points that walk in human body lower limbs, and most of acupuncture point all has the function of the headache of curing, hypertension symptom such as dizzy in these 26 acupuncture points on the science of acupuncture and moxibustion.
For showing the present invention to hypertensive therapeutic effect, the present invention was through 100 routine hypertensive patient's clinical observations, and effective percentage 99% applies three times, and cure rate 80% was followed up a case by regular visits to the nothing recurrence through 3 years.
Using method is got and is mixed powder 120 gram, and with Ovum Gallus domesticus furnishing pasty state, external application is in appointed part, or powder 100 grams are immersed in 1 jin, a traditional unit of weight of leachate, gets leachate coating appointed part.8-18 hour external application time is for once, the next day carry out treatment next time.
Embodiment:
Take by weighing raw material (gram) by following proportioning
Semen Momordicae 55, Semen Pharbitidis 30, Semen Pharbitidis 25, Radix orixae japonicae 1.5, pulverize, 80 orders sieve, and with powder mixing packing patent medicine, get 4 pieces of Ovum Galluss domesticus during use, break and pour out content, with medicated powder furnishing pasty state, be coated in sp 6 with lower limb, foot outer surface down to Yongquan acupoint, Xiangu point line, 15 hours external application time.
Claims (3)
1, treats hypertensive liniment, it is characterized in that it is the medicament of being made by the following weight proportion raw material: Semen Momordicae 30-60, Semen Pharbitidis 15-45, Semen Pharbitidis 20-40, Radix orixae japonicae 1-4.
2, according to the hypertensive liniment of the treatment described in the claim 1, wherein the weight proportion of each raw material is:
Semen Momordicae 55, Semen Pharbitidis 30, Semen Pharbitidis 25, Radix orixae japonicae 1.5.
3, the hypertensive liniment of treatment according to claim 1 and 2 is characterized in that behave any dosage form in the external application of said medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991091884A CN1175829C (en) | 1999-06-22 | 1999-06-22 | External application medicine for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991091884A CN1175829C (en) | 1999-06-22 | 1999-06-22 | External application medicine for treating hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1277864A true CN1277864A (en) | 2000-12-27 |
| CN1175829C CN1175829C (en) | 2004-11-17 |
Family
ID=5273743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB991091884A Expired - Fee Related CN1175829C (en) | 1999-06-22 | 1999-06-22 | External application medicine for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1175829C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520288A (en) * | 2011-07-28 | 2014-01-22 | 冯亚西 | External drug for treating heart disease and vasculitis, and its application |
| CN110840891A (en) * | 2018-08-20 | 2020-02-28 | 山西医科大学 | Hypotensive medicine-Panmust (Pempidine) as new type antiarrhythmic medicine |
-
1999
- 1999-06-22 CN CNB991091884A patent/CN1175829C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520288A (en) * | 2011-07-28 | 2014-01-22 | 冯亚西 | External drug for treating heart disease and vasculitis, and its application |
| CN110840891A (en) * | 2018-08-20 | 2020-02-28 | 山西医科大学 | Hypotensive medicine-Panmust (Pempidine) as new type antiarrhythmic medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1175829C (en) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
| CN1077795C (en) | Chinese patent medicine for treating headache | |
| CN101125166A (en) | External-applied traditional Chinese medicine for treating rheumatism | |
| CN1175829C (en) | External application medicine for treating hypertension | |
| CN1621051A (en) | Hyperosteogeny plaster | |
| CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
| CN1064245C (en) | Medicine for hyperosteogeny | |
| CN102188555B (en) | Health-care wine for treating rheumatism | |
| CN105148013A (en) | Traditional Chinese medicine for treating cervical spondylopathy | |
| CN1985906B (en) | Specific medicine for treating rheumatism and bone spur | |
| CN1060954C (en) | External use Chinese drug powder and its preparing method and medicinal pad | |
| CN108743818A (en) | External application is dispelled osteoarthropathy medicinal liquor | |
| CN103736050A (en) | Foot bath traditional Chinese medicine prescription for promoting blood circulation and tonifying kidney | |
| CN100360158C (en) | Chinese medicine prepn for promoting blood circulation and dredging meridian passage | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN106491921A (en) | Rheumatism plaster comprising Os Tigriss and preparation method thereof | |
| CN101703541B (en) | Four-species medicinal powder for treating leukoderma | |
| CN101099773A (en) | Hyperosteogeny-treating plaster | |
| CN100998770A (en) | Hypertensor plaster with tranquilizing function | |
| CN105770322A (en) | Preparation method of medical liquor for treating blood-stasis type lumbago | |
| CN1169532C (en) | Liquor for treating rheumatism and arthritis | |
| CN1605350A (en) | Medicine for treating hyperosteogeny | |
| CN101007070B (en) | Prescription for treating rheumatic or rheumatoid diseases and traumatic injury | |
| CN109464534A (en) | Composition for preventing and treating burn and scald and preparation method thereof | |
| CN1050288C (en) | Traditional Chinese medicine oral liquid for treating soft tissue pain of waist and legs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041117 Termination date: 20120622 |